Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis
- PMID: 23801461
- DOI: 10.1002/alr.21193
Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis
Abstract
Background: Rhinitis is an extremely common medical problem characterized by nasal congestion, clear rhinorrhea, sneezing, and itching. Hyaluronate is an endogenous compound that has an important role in mucociliary clearance by the epithelial surface of the nasal passages and in mucosal surface healing and repair. The objective of this work was to determine the effects of intranasal administration of sodium hyaluronate on nasal cytology in patients with allergic and nonallergic rhinitis.
Methods: In a single-center, randomized, blinded trial, 78 patients received intranasal mometasone and oral desloratadine plus either intranasal sodium hyaluronate or saline for 1 month. Nasal cytology was performed and the change from baseline in the numbers of neutrophils, eosinophils, mast cells, lymphocytes, and infective species was determined. Other outcomes included changes in symptoms and the endoscopic appearance of the nasal mucosa, and tolerability.
Results: Patients receiving sodium hyaluronate experienced a significant decrease in the median neutrophil count seen on nasal cytology compared with controls (p = 0.001). Sodium hyaluronate was associated with significant improvements in sneezing, rhinorrhea, and nasal congestion, and on exudate seen on endoscopy at 1 month compared with baseline. Intranasal sodium hyaluronate received better tolerability scores than saline over the 1-month treatment period.
Conclusion: The addition of sodium hyaluronate to intranasal corticosteroid and systemic antihistamine reduced the neutrophil count seen on nasal cytology in patients with allergic and nonallergic rhinitis and improved several clinical and endoscopic parameters while being well tolerated. These data provide encouraging evidence of the efficacy of sodium hyaluronate in the treatment of this common disease.
Keywords: Yabro®; allergic rhinitis; eosinophils; intranasal corticosteroids; nasal cytology; neutrophils; nonallergic rhinitis; rhinological therapies; sodium hyaluronate; vasomotor rhinitis.
© 2013 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals, Inc., on behalf of ARS-AAOA, LLC.
Similar articles
-
Effect of sodium hyaluronate on mucociliary clearance after functional endoscopic sinus surgery.Eur Ann Allergy Clin Immunol. 2013 May;45(3):103-8. Eur Ann Allergy Clin Immunol. 2013. PMID: 23862400 Clinical Trial.
-
Hyaluronan plus saline nasal washes in the treatment of rhino-sinusal symptoms in patients undergoing functional endoscopic sinus surgery for rhino-sinusal remodeling.Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):137-45. doi: 10.1177/039463201302600113. Int J Immunopathol Pharmacol. 2013. PMID: 23527716 Clinical Trial.
-
Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.Am J Rhinol Allergy. 2010 Jan-Feb;24(1):29-33. doi: 10.2500/ajra.2010.24.3423. Am J Rhinol Allergy. 2010. PMID: 20109317 Clinical Trial.
-
Allergic Rhinitis: A Review.JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. JAMA. 2024. PMID: 38470381 Review.
-
Allergic and nonallergic rhinitis.Allergy Asthma Proc. 2019 Nov 1;40(6):376-379. doi: 10.2500/aap.2019.40.4251. Allergy Asthma Proc. 2019. PMID: 31690374 Review.
Cited by
-
Efficacy of sodium hyaluronate in relieving nasal symptoms of children with intermittent allergic rhinitis: a randomized controlled trial.Eur Arch Otorhinolaryngol. 2022 Jun;279(6):2925-2934. doi: 10.1007/s00405-021-07073-0. Epub 2021 Sep 16. Eur Arch Otorhinolaryngol. 2022. PMID: 34529156 Clinical Trial.
-
Clinical Evidence of Type 2 Inflammation in Non-allergic Rhinitis with Eosinophilia Syndrome: a Systematic Review.Curr Allergy Asthma Rep. 2022 Apr;22(4):29-42. doi: 10.1007/s11882-022-01027-0. Epub 2022 Feb 9. Curr Allergy Asthma Rep. 2022. PMID: 35141844
-
Topical administration of hyaluronic acid in children with recurrent or chronic middle ear inflammations.Int J Immunopathol Pharmacol. 2016 Sep;29(3):438-42. doi: 10.1177/0394632016656012. Epub 2016 Jun 24. Int J Immunopathol Pharmacol. 2016. PMID: 27481884 Free PMC article. Clinical Trial.
-
Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1423-1429. doi: 10.1007/s00405-016-4327-4. Epub 2016 Oct 1. Eur Arch Otorhinolaryngol. 2017. PMID: 27695944 Clinical Trial.
-
"Commentary to: 'Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease'"?Eur Arch Otorhinolaryngol. 2018 Mar;275(3):827-828. doi: 10.1007/s00405-017-4568-x. Epub 2017 May 4. Eur Arch Otorhinolaryngol. 2018. PMID: 28474190 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources